Patents by Inventor Burt Timothy Richards

Burt Timothy Richards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HTRA1 MODULATION FOR TREATMENT OF AMD
    Publication number: 20230165976
    Abstract: The invention provides compositions and methods for treatment of Chromosome 10-driven age-related macular degeneration, including gene therapy to increase HTRA1 expression in retinal pigmented epithelial cells in the eye.
    Type: Application
    Filed: April 10, 2020
    Publication date: June 1, 2023
    Inventors: Brandi Williams, Gregory Hageman, Burt Timothy Richards, Osama Youssef
  • GENE THERAPY FOR MACULAR DEGENERATION
    Publication number: 20210338838
    Abstract: The invention provides compositions and methods for treatment of age-related macular degeneration, including gene therapy employing vectors and transgenes expressing protective CFH polypeptide and CFHT polypeptide sequences.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 4, 2021
    Inventors: Gregory Scott HAGEMAN, Burt Timothy RICHARDS
  • Retinoid pathway assays, and compositions therefrom
    Publication number: 20020081688
    Abstract: Methods for assaying a cellular pathway, and more particularly a retinoic acid-related pathway, are disclosed. The assays of the invention utilize particular host cells with desired retinoic acid pathway elements, and results in the identification of biologically active phenotypic probes and cellular targets and fragments, variants and mimetics thereof.
    Type: Application
    Filed: November 16, 2001
    Publication date: June 27, 2002
    Inventors: Carl Alexander Kamb, Burt Timothy Richards, Jon Karpilow